| Financial Year |
March 31 2023 |
| Monetary Funds |
584,794,120.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,475,000.00 |
| Accounts Receivable |
371,849,356.70 |
| Advances to Suppliers |
212,013,100.06 |
| Other Receivables |
37,804,492.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,457,407,774.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,372,177.57 |
| Total Current Assets |
3,768,013,582.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,351,931.06 |
| Fixed Assetes |
836,870,375.76 |
| Under-construction Projects |
670,720,298.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
261,607,149.54 |
| R&D expenses |
308,513,629.72 |
| Goodwill |
1,777,888.11 |
| Long-Term Deferred and Prepaid Expenses |
1,931,157.32 |
| Deferred Income Tax Assets |
9,767,602.79 |
| Other Non-Current Assets |
125,308,837.60 |
| Sub-Total of Non-Current Assets |
2,220,639,006.27 |
| Total Assets |
5,988,652,588.93 |
| Short-Term Loans |
1,034,922,546.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,495,810.00 |
| Accounts Payable |
136,945,675.38 |
| Accounts Received In Advance |
43,567,624.23 |
| Employee Compensation Payable |
30,747,695.35 |
| Taxes Payable |
22,585,417.94 |
| Interest Payable |
1,471,743.92 |
| Dividend Payable |
-- |
| Other payables |
47,291,132.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
435,282,528.78 |
| Other Current Liabilities |
4,145,845.30 |
| Sub-Total of Current Liabilities |
1,820,228,598.34 |
| Long-term Loans |
1,049,735,388.47 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
189,576.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,114,521,857.61 |
| Total Liabilities |
2,934,750,455.95 |
| Paid-In Capital(Or Share Stock) |
934,966,878.00 |
| Capital Surplus |
526,841,889.26 |
| Surplus Reserve |
185,639,365.56 |
| LESS:Treasury Stock |
120,010,884.81 |
| Undistributed Profits |
1,613,009,617.67 |
| Minority Stockholder's Interest |
-8,004,937.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,061,907,070.59 |
| Owner's Equity（Stockholder's Equity） |
3,053,902,132.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,988,652,588.93 |
